The Cooper Companies, Inc. (COO) Cash Flow Statement

The Cooper Companies, Inc. (COO) generated $1.0B of operating cash flow over the twelve months to 2026-07-31, spent $355.3M on capital expenditure and had free cash flow of $678.0M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-07-31 · read by EquiReason

COOThe Cooper Companies, Inc.Follow COO — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 11.6B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 2 Dec, in 39 days

Line	FY2010 Oct 10	FY2011 Oct 11	FY2012 Oct 12	FY2013 Oct 13	FY2014 Oct 14	FY2015 Oct 15	FY2016 Oct 16	FY2017 Oct 17	FY2018 Oct 18	FY2019 Oct 19	FY2020 Oct 20	FY2021 Oct 21	FY2022 Oct 22	FY2023 Oct 23	FY2024 Oct 24	FY2025 Oct 25	TTM Jul 26
Operating cash flow	0.27	0.34	0.32	0.42	0.45	0.39	0.51	0.59	0.67	0.71	0.49	0.74	0.69	0.61	0.71	0.80	1.03
Capital expenditure	0.07	0.10	0.10	0.18	0.24	0.24	0.15	0.13	0.19	0.29	0.31	0.21	0.24	0.39	0.42	0.36	-0.36
Free cash flow	0.19	0.23	0.22	0.24	0.22	0.15	0.36	0.47	0.48	0.42	0.18	0.52	0.45	0.22	0.29	0.43	0.68
Dividends paid	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Share repurchases	—	—	0.07	0.17	0.08	0.07	0.00	0.06	0.00	0.16	0.05	0.02	0.08	0.00	0.00	0.29	—
Stock-based compensation	0.01	0.01	0.02	0.03	0.04	0.03	0.03	0.04	0.04	0.04	0.04	0.04	0.05	0.06	0.08	0.07	—

USD billions · SEC XBRL

The Cooper Companies, Inc. — questions

What is The Cooper Companies, Inc.'s operating cash flow?: $1.0B over the twelve months to 2026-07-31.
How much does The Cooper Companies, Inc. spend on capital expenditure?: $355.3M over the twelve months to 2026-07-31.
What is The Cooper Companies, Inc.'s free cash flow?: $678.0M over the twelve months to 2026-07-31: operating cash flow minus capital expenditure.

Every figure on this page comes from The Cooper Companies, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.